Skip to main content
Enterprise AI Analysis: The effect of remote treatment on medical provider creative thinking and patient disclosure: protocol for the MED-CREATE trial

The effect of remote treatment on medical provider creative thinking and patient disclosure: protocol for the MED-CREATE trial

Unlocking Enhanced Healthcare: Remote Treatment and its Impact

This groundbreaking study protocol (MED-CREATE trial) explores the dual impact of remote treatment modalities on medical provider creativity and patient disclosure, aiming to optimize telehealth strategies for improved patient care.

0 Total Participants (Dyads)
0 Intervention Arms
NCT06784635 ClinicalTrials.gov ID

Strategic Implications for Healthcare Delivery

The MED-CREATE trial offers critical insights for healthcare executives seeking to leverage telehealth effectively. Understanding the trade-offs between online and in-person consultations can drive strategic resource allocation and enhance patient outcomes.

Key Strategic Benefits

  • Informing telehealth policy and infrastructure development.
  • Optimizing clinician training programs for virtual care.
  • Tailoring communication strategies for sensitive patient disclosures.
  • Enhancing diagnostic accuracy in remote settings.

Deep Analysis & Enterprise Applications

Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.

Medical Research Protocol
194 Medical Student-Patient Dyads

The study aims to recruit 194 medical student-patient dyads (388 participants total) to ensure statistically significant findings on communication modality.

MED-CREATE Trial Design Flow

Eligibility Screening & Consent
Randomization (Online vs. Offline)
Baseline Measures (Health Literacy, Personality, WM)
Consultation Session (Medical Student & Acting Patient)
Outcome Assessments (Diagnoses, Disclosure, Fatigue, Empathy)
Debriefing & Data Transcription

Hypothesized Modality Impacts

Aspect Online (Hypothesized) Offline (Hypothesized)
Creative Idea Generation
  • Fewer diagnoses (H1a)
  • Lower correct diagnosis rate (H1b)
  • More diagnoses
  • Higher correct diagnosis rate
Patient Disclosure
  • More details on embarrassing topics (H2)
  • Less details on embarrassing topics
Clinician Factors
  • Reduced creativity with low empathy, WM, extraversion, openness (H3a, H3b)
  • Enhanced creativity with high empathy, WM, extraversion, openness
Patient Factors
  • Increased disclosure with higher health literacy (H4)
  • Decreased disclosure with lower health literacy

Addressing Diagnostic Challenges in Telehealth

A core objective of the MED-CREATE trial is to examine how communication modality impacts clinicians' ability to generate solutions to complex clinical problems. Previous research suggests that online interactions may inhibit creative thinking, which is crucial for differential diagnosis and identifying rare conditions. By simulating challenging patient cases, the study will provide empirical evidence on whether telehealth platforms hinder or support the diagnostic process, particularly when divergent thinking and problem sensitivity are required.

Calculate Your Potential ROI with AI Integration

Estimate the significant time and cost savings your enterprise could achieve by implementing AI-powered solutions based on research-backed insights.

Estimated Annual Savings $0
Total Hours Reclaimed Annually 0

Your AI Implementation Roadmap

A structured approach to integrating AI solutions, ensuring a smooth transition and maximum impact for your enterprise.

MED-CREATE Trial Execution Phases

Phase 1: Setup & Recruitment

Finalize IRB approval, recruit medical students and acting patients, establish secure online and in-person consultation environments, and configure REDCap for data management.

Phase 2: Data Collection

Conduct randomized controlled consultations, collect baseline psychometric data, record interactions, and administer post-consultation questionnaires.

Phase 3: Data Processing & Analysis

Transcribe audio recordings, anonymize data, perform statistical analysis on primary and secondary outcomes using R, and interpret findings.

Phase 4: Dissemination & Reporting

Publish results in peer-reviewed journals, present at scientific conferences, and make de-identified data and analysis code publicly available.

Ready to Optimize Your Healthcare Solutions?

Partner with OwnYourAI to integrate cutting-edge research findings into your telehealth strategy. Schedule a personalized session to explore how our AI-powered insights can enhance your patient care and operational efficiency.

Ready to Get Started?

Book Your Free Consultation.

Let's Discuss Your AI Strategy!

Lets Discuss Your Needs


AI Consultation Booking